SUPRAX (Page 7 of 7)

17 PATIENT COUNSELING INFORMATION

17.1 Information for Patients

Counsel patients that antibacterial drugs, including cefixime, should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When cefixime is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may: (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by cefixime for oral suspension or cefixime chewable tablets or other antibacterial drugs in the future.

Counsel patients with phenylketonuria that SUPRAX chewable tablets contain aspartame, a source of phenylalanine as follows: Each SUPRAX chewable tablet contains 3.3 mg, 5 mg and 6.7 mg of phenylalanine per 100 mg, 150 mg and 200 mg strength, respectively.

Advise patients that diarrhea is a common problem caused by antibacterial drugs which usually ends when the antibacterial drug is discontinued. Sometimes after starting treatment with antibacterial drugs, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibacterial drug. If this occurs, patients should contact their physician as soon as possible.

Products Manufactured for: Manufactured by:
SUPRAX ® (cefixime) tablets, 400 mg
SUPRAX ® (cefixime) capsules, 400 mg
SUPRAX ® (cefixime) chewable tablets, 100 mg, 150 mg and 200 mg Lupin Pharma Baltimore, Maryland 21202 United States.
SUPRAX ® (cefixime) for oral suspension, 200 mg/5 mL Lupin Limited Mandideep 462 046 India.
SUPRAX ® (cefixime) for oral suspension, 500 mg/5 mL
SUPRAX ® (cefixime) for oral suspension, 100 mg/5 mL Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States

ID#: 254614

SUPRAX® CEFIXIME FOR ORAL SUSPENSION USP

100 mg/5 mL

Rx only

NDC 68180-202-03: Bottle of 50 mL

SUPRAX CEFIXIME FOR ORAL SUSPENSION USP
100 mg/5 mL
Rx only
						NDC 68180-202-03: Bottle of 50 mL
(click image for full-size original)

SUPRAX® CEFIXIME FOR ORAL SUSPENSION USP

100 mg/5 mL

Rx only

NDC 68180-202-04: Bottle of 10 mL (Physician Sample Pack)

NDC 68180-202-05: Carton for 10 mL x 6 Bottles (Physician Sample Pack)

SUPRAX CEFIXIME FOR ORAL SUSPENSION USP
100 mg/5 mL
Rx only
						NDC 68180-202-04: Bottle of 10 mL (Physician Sample Pack)
(click image for full-size original)
SUPRAX CEFIXIME FOR ORAL SUSPENSION USP
100 mg/5 mL
Rx only
						NDC 68180-202-05: Carton for 10 mL x 6 Bottles (Physician Sample Pack
(click image for full-size original)
SUPRAX cefixime powder, for suspension
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68180-202
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CEFIXIME (CEFIXIME ANHYDROUS) CEFIXIME ANHYDROUS 100 mg in 5 mL
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
SODIUM BENZOATE
STRAWBERRY
SUCROSE
XANTHAN GUM
Product Characteristics
Color WHITE (off-white to pale yellow) Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68180-202-05 6 BOTTLE in 1 CARTON contains a BOTTLE (68180-202-04)
1 NDC:68180-202-04 10 mL in 1 BOTTLE This package is contained within the CARTON (68180-202-05)
2 NDC:68180-202-03 50 mL in 1 BOTTLE None
3 NDC:68180-202-02 75 mL in 1 BOTTLE None
4 NDC:68180-202-01 100 mL in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA065129 03/01/2004
Labeler — Lupin Pharmaceuticals, Inc. (089153071)
Registrant — LUPIN LIMITED (675923163)
Establishment
Name Address ID/FEI Operations
LUPIN LIMITED 725504448 MANUFACTURE (68180-202)

Revised: 01/2020 Lupin Pharmaceuticals, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.